semaglutide and thyroid (Ozempic) carries FDA warnings for C-cell tumors based on rodent studies, with emerging human data showing higher thyroid cancer risk in early users. Over 2,900 lawsuits allege inadequate warnings for The package insert for Ozempic
Description
Hypoglycaemic agents in patients with heart failure
Semaglutide is extremely effective for helping obese and overweight patients lose weight
The money question lingers uncomfortably
The observed improvements with semaglutide were possibly influenced, at least in part, by changes in HbA1c and body weight
Dropping from 1 mg back to 0.5 mg means levels will gradually decline over several weeks rather than immediately dropping
The brain is reward response to food intensifies
